Nate, 55, a smoker, has seen three dermatologists for a rash that seems to be resistant to various treatments. He has complained that he has had a chronic bumpy and painful rash with pustules ...

HUNTINGTON BEACH, California — When patients of Aaron Mangold, MD, first learn they have mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma (CTCL), some are concerned ...

The skin is the largest organ in the body and can often reveal signs of underlying health conditions, including blood cancers such as leukemia and lymphoma. According to The University of Texas MD ...

The US Food and Drug Administration has approved denileukin diftitox-cxdl (Lymphir, Citius Pharmaceuticals) for adults with relapsed or refractory stage 1-3 cutaneous T-cell lymphoma after at least ...

Tattoos may increase the risk of developing lymphoma and skin cancer, a recent study suggests. "We can see that ink particles accumulate in the lymph nodes, and we suspect that the body perceives them ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab-treated patients with AD were 4.1003 times more likely to develop cutaneous T-cell lymphoma vs. those ...

PRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare ...

A nurse practitioner asks for an opinion regarding a skin lesion on a 39-year-old African American man. The lesion is located on the inner left thigh and is mildly pruritic. It measures an irregular ...

Title: Results from a Pilot Study of HyBryte™ (topical synthetic hypericin) versus Valchlor® (mechlorethamine) in the Treatment of CTCL attended by Dr. Christopher Pullion, Medical Director, Soligenix ...